tetraiodothyroacetic acid has been researched along with Experimental Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mousa, SA; Rajabi, M; Yalcin, M | 1 |
| Ahn, J; Choe, YS; Choi, JY; Kim, BT; Kim, H; Kim, JY; Koo, HJ; Lee, KH | 1 |
2 other study(ies) available for tetraiodothyroacetic acid and Experimental Neoplasms
| Article | Year |
|---|---|
Synthesis of new analogs of tetraiodothyroacetic acid (tetrac) as novel angiogenesis inhibitors for treatment of cancer.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, Inbred C57BL; Molecular Structure; Neoplasms; Neoplasms, Experimental; Neovascularization, Pathologic; Structure-Activity Relationship; Thyroxine | 2018 |
Synthesis and characterization of
Topics: Animals; Brain Neoplasms; Carbocyanines; Cells, Cultured; Copper Radioisotopes; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Neovascularization, Pathologic; Positron-Emission Tomography; Thyroxine | 2020 |